Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)-Reference-Cited by-同舟云学术

Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)

Published:2016-08 Issue:8 Volume:2 Page:e00147
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Fraleigh Nya L.,Boudreau Justin,Bhardwaj Nitin,Eng Nelson F.,Murad Yanal,Lafrenie Robert,Acevedo Reinaldo,Oliva Reynaldo,Diaz-Mitoma Francisco,Le Hoang-Thanh

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference44 articles.

1. World Health Organization;Tobacco Fact Sheet,2014

2. Tobacco use in Canada: patterns and trends;Reid,2012

3. Immunopharmacotherapy vaccination strategies as a treatment for drug abuse and dependence;Moreno;Pharmacol. Biochem. Behav.,2009

4. A vaccine against nicotine for smoking cessation: a randomized controlled trial;Cornuz;PLoS ONE,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel immunomodulatory properties of low dose cytarabine entrapped in a mannosylated cationic liposome;International Journal of Pharmaceutics;2021-09

2. Assessing Neutralized Nicotine Distribution Using Mice Vaccinated with the Mucosal Conjugate Nicotine Vaccine;Vaccines;2021-02-03

3. Intranasal delivery of a nicotine vaccine candidate induces antibodies in mouse blood and lung mucosal secretions that specifically neutralize nicotine;Drug Development and Industrial Pharmacy;2020-09-15

4. Enhancing the Immune Response of a Nicotine Vaccine with Synthetic Small “Non-Natural” Peptides;Molecules;2020-03-12

5. Repeat-Dose Toxicity Study Using the AFPL1-Conjugate Nicotine Vaccine in Male Sprague Dawley Rats;Pharmaceutics;2019-11-23